Analyzing T cell responses : how to analyze cellular immune responses against tumor associated antigens /

Saved in:
Bibliographic Details
Imprint:Dordrecht, the Netherlands : Springer, c2005.
Description:1 online resource (xii, 313 p.) : ill. (some col.)
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8874626
Hidden Bibliographic Details
Other authors / contributors:Nagorsen, Dirk.
Marincola, Francesco M.
ISBN:1402036221 (hd. bd. : alk. paper)
9781402036224 (hd. bd. : alk. paper)
140203623X (e-book)
9781402036231 (e-book)
Notes:Includes bibliographical references and index.
Summary:Emphasizing a global approach to the analysis of T cell mediated target/host interactions at the systemic and the peripheral level when such interactions are supposed to occur, this book provides a critical assessment of the assays that have been used for the monitoring of antigen-specific immune responses.
Other form:Print version: Analyzing T cell responses. Dordrecht, the Netherlands : Springer, c2005 1402036221
Description
Summary:Active specific immunotherapy is a promising but investigational modality in the management of cancer patients. Currently, several different cancer vaccine formulations such as peptides, proteins, antigen-pulsed dendritic cells, whole tumor cells, etc. in combination with various adjuvants and carriers are being evaluated in clinical trials (1-3). To determine the optimal cancer vaccine strategy, a surrogate immunological end-point that correlates with clinical outcome needs to be defined, since it would facilitate the rapid comparison of these various formulations. Traditional immunological assays such as ELISA, proliferation and cytotoxicity assays can detect immune responses in vaccinated patients but are not quantitative. In contrast, novel assays such as enzyme-linked immunospot (ELISPOT) assay, intracellular cytokine assay and tetramer assay can quantitate the frequency of antigen-specific T cells. Of these, the ELISPOT assay has the 5 lowest detection limit with 1/10 peripheral blood mononuclear cells (PBMC) and has been determined to be one of the most useful assays to evaluate immune response to cancer vaccines (4). However, the IFN-? ELISPOT assay is not an exclusive measure of cytotoxic T-lymphocyte (CTL) activity as non-cytotoxic cells can also secrete IFN-?. Additionally, CTL with lytic activity do not always secrete IFN-? (5). A more relevant approach to assess functional activity of cytotoxic lymphocytes would be to measure the secretion of molecules that are associated with lytic activity. One of the major mechanisms of cell-mediated cytotoxicity involves exocytosis of cytoplasmic granules from the effector toward the target cell.
Physical Description:1 online resource (xii, 313 p.) : ill. (some col.)
Bibliography:Includes bibliographical references and index.
ISBN:1402036221
9781402036224
140203623X
9781402036231